Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation—data from the prospective IVEPSA study

Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation—data from the prospective IVEPSA study

Abstract Background A specific subset of psoriasis patients is characterized by subclinical inflammatory changes. These patients frequently present with arthralgia and have a higher risk to develop psoriatic arthritis (PsA). We hypothesized that IL-17A inhibition in this subset of patients can inter...

Full description

Bibliographic Details
Main Authors: Eleni Kampylafka, David Simon, Isabelle d’Oliveira, Christina Linz, Veronika Lerchen, Matthias Englbrecht, Juergen Rech, Arnd Kleyer, Michael Sticherling, Georg Schett, Axel J. Hueber
Format: Article
Language:English
Published: BMC 2019-07-01
Series:Arthritis Research & Therapy
Subjects:
Psoriasis
Psoriatic arthritis
Interleukin-17
Magnetic resonance imaging
Online Access:http://link.springer.com/article/10.1186/s13075-019-1957-0

Internet

http://link.springer.com/article/10.1186/s13075-019-1957-0

Similar Items